Literature DB >> 33939509

Medicare Beneficiaries With Self-Reported Functional Hearing Difficulty Have Unmet Health Care Needs.

Nicholas S Reed1, Lama Assi2, Wakako Horiuchi3, Julie E Hoover-Fong4, Frank R Lin5, Lauren E Ferrante6, Sharon K Inouye7, Edgar R Miller Iii8, Emily F Boss9, Esther S Oh10, Amber Willink11.   

Abstract

Hearing loss is associated with higher health care spending and use, but little is known about the unmet health care needs of people with hearing loss or difficulty. Analysis of 2016 Medicare Current Beneficiary Survey data for beneficiaries ages sixty-five and older reveals that those who reported a lot of trouble hearing in the past year were 49 percent more likely than those who reported no trouble hearing to indicate not having a usual source of care. Compared with those who reported no trouble hearing, those who reported some trouble hearing were more likely to indicate not having obtained medical care in the past year when they thought it was needed, as well as not filling a prescription, with the risk for both behaviors being greater among those reporting a lot of trouble hearing versus a little. Interventions that improve access to hearing services and aid communication may help older Medicare beneficiaries meet their health care needs.

Entities:  

Year:  2021        PMID: 33939509     DOI: 10.1377/hlthaff.2020.02371

Source DB:  PubMed          Journal:  Health Aff (Millwood)        ISSN: 0278-2715            Impact factor:   6.301


  2 in total

1.  Alternative Pathways for Hearing Care May Address Disparities in Access.

Authors:  Amber Willink; Lama Assi; Carrie Nieman; Catherine McMahon; Frank R Lin; Nicholas S Reed
Journal:  Front Digit Health       Date:  2021-11-25

2.  Longitudinal Associations of Self-Reported Visual, Hearing, and Dual Sensory Difficulties With Symptoms of Depression Among Older Adults in the United States.

Authors:  Olivia J Killeen; Xiaoling Xiang; Danielle Powell; Nicholas S Reed; Jennifer A Deal; Bonnielin K Swenor; Joshua R Ehrlich
Journal:  Front Neurosci       Date:  2022-01-27       Impact factor: 4.677

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.